Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Targacept's $75M Stock Offering Targets Cognitive Disorders R&D
Targacept's $75M Stock Offering Targets Cognitive Disorders R&D
Targacept's $75M Stock Offering Targets Cognitive Disorders R&D
Submitted by
admin
on May 18, 2011 - 11:29am
Source:
Motley Fool
News Tags:
AstraZeneca
Targacept
stock offering
R&D
schizophrenia
Headline:
Targacept's $75M Stock Offering Targets Cognitive Disorders R&D
Do Not Allow Advertisers to Use My Personal information
